Show simple item record

dc.contributor.authorvan den Beld, Maaike J C
dc.contributor.authorMurk, Jean-Luc
dc.contributor.authorKluytmans, Jan
dc.contributor.authorKoopmans, Marion P G
dc.contributor.authorReimerink, Johan
dc.contributor.authorvan Loo, Inge H M
dc.contributor.authorWegdam-Blans, Marjolijn C A
dc.contributor.authorZaaijer, Hans
dc.contributor.authorGeurtsvanKessel, Corine
dc.contributor.authorReusken, Chantal
dc.date.accessioned2021-07-15T19:40:00Z
dc.date.available2021-07-15T19:40:00Z
dc.date.issued2021-06-30
dc.identifier.pmid34191578
dc.identifier.doi10.1128/JCM.00767-21
dc.identifier.urihttp://hdl.handle.net/10029/625090
dc.language.isoenen_US
dc.titleIncreasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.en_US
dc.typeArticleen_US
dc.identifier.eissn1098-660X
dc.identifier.journalJ Clin Microbiol 2021; 59(9):e00767-21en_US
dc.source.journaltitleJournal of clinical microbiology
dc.source.beginpageJCM0076721
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record